In a 280 to 140 vote, the U.S. House of Representatives has passed the Protect Medical Innovation Act (HR 160), which would repeal the 2.3% medical device excise tax.
Sponsored by Reps. Erik Paulsen (R-MN) and Ron Kind (D-WI), the bill was introduced in January with 254 co-sponsors. It has been supported by the Medical Imaging and Technology Alliance (MITA), the Advanced Medical Technology Association (AdvaMed), and the Medical Device Manufacturers Association (MDMA).
"The House of Representatives sent a strong, bipartisan message that it is time to put an end to this tax on innovation," said Mark Leahey, president and CEO of MDMA. "Repealing this policy will provide an immediate boost for medical technology innovators to continue solving the pressing challenges in the healthcare ecosystem."
